Trials / Completed
CompletedNCT01688245
A Text Message Behavioral Intervention to Reduce Alcohol Consumption in Young Adults
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 765 (actual)
- Sponsor
- University of Pittsburgh · Academic / Other
- Sex
- All
- Age
- 18 Years – 25 Years
- Healthy volunteers
- Not accepted
Summary
Investigators aim to test the effectiveness of a text-message-based behaivoral intervention in reducing binge drinking among young adults.
Detailed description
Alcohol consumption, especially in the form of heavy episodic drinking (bingeing), is common among young adults. Despite high rates of illness and injury associated with heavy episodic drinking, many young adults are not aware of the risks, few seek help for their drinking and many at-risk are not exposed to prevention-based intervention. Opportunistic screening in hospital Emergency Departments (EDs) tied to behavioral interventions has the potential to prevent future alcohol-related harm among young adults, but efficacy across outcomes has been mixed and large-scale implementation of prevention programs is low. Given the rapidly growing use of cell phone text-messaging (SMS) as a primary form of communication among young adults, SMS could be used to deliver health prevention interventions. We will recruit young adults identified in the ED with hazardous drinking behavior in a 3-arm randomized controlled trial to test the hypothesis that exposure to a 12-week SMS program will result in immediate (3-month) and lasting (6-, and 9-month) decreases in alcohol consumption.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | SMS Assessments & Feedback | Weekly pre-weekend drinking plan and post-weekend drinking outcome assessments with personlaized feedback |
| BEHAVIORAL | SMS Assessments | Weekly post-weekend drinking outcome assessments |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2014-11-01
- Completion
- 2015-05-01
- First posted
- 2012-09-19
- Last updated
- 2015-05-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01688245. Inclusion in this directory is not an endorsement.